Periadventitial angiopoietin-1 gene transfer induces angiogenesis in rabbit carotid arteries

被引:0
作者
S Bhardwaj
H Roy
T Kärpänen
Y Hi
S Jauhiainen
M Hedman
K Alitalo
S Ylä-Herttuala
机构
[1] University of Kuopio,Department of Biotechnology and Molecular Medicine, A.I.Virtanen Institute for Molecular Sciences
[2] University of Helsinki,Molecular/Cancer Biology Laboratory, Haartman Institute
[3] University of Kuopio,Department of Medicine
[4] Kuopio University Hospital,Gene Therapy Unit
来源
Gene Therapy | 2005年 / 12卷
关键词
angiopoietins; angiogenesis; neovessels; VEGF receptor-1-Ig;
D O I
暂无
中图分类号
学科分类号
摘要
This study was performed to evaluate angiogenic responses of angiopoietin-1 (Ang1) in vivo after adenovirus-mediated gene transfer in the periadventitial space of the rabbit carotid arteries using a collar technique. Adenoviruses encoding LacZ and vascular endothelial growth factor (VEGF) receptor-1-Ig fusion protein (VEGF-R1-Ig) adenoviruses were used as controls. Increased neovessel formation was seen in adventitia of the Ang1 transduced arteries 7 days after the gene transfer. Neovessels in the Ang1 transduced arteries were large in size and well perfused. Ang1 binds to Tie2 (tyrosine kinase with immunoglobulin and epidermal growth factor homology domain) receptors, which were expressed in the endothelium of the neovessels. When VEGF-R1-Ig was used with Ang1, it resulted in a decrease in the number of neovessels, which implies that VEGF-A or some other VEGF-R1 ligand(s) play a crucial role in angiogenesis occurring in response to Ang1. There were no significant differences in the total number of capillaries in the adventitia of the VEGF-R1-Ig transduced arteries as compared to LacZ controls. Neointima formation was not increased in the Ang1 transduced arteries as compared to the controls. We conclude that in the periadventitial space Ang1 shows angiogenic activity and is a potentially useful factor for the induction of therapeutic vascular growth in vivo.
引用
收藏
页码:388 / 394
页数:6
相关论文
共 55 条
  • [11] Dumont DJ(2000)Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis Circ Res 87 603-607
  • [12] Suri C(2000)Is angiopoietin-2 necessary for the initiation of tumor angiogenesis? Arterioscler Thromb Vasc Biol 20 2573-2578
  • [13] Lauren J(2000)Angiopoietin-1 is an antipermeability and anti-inflammatory agent Nat Med 6 460-463
  • [14] Gunji Y(1999) and targets cell junctions Science 286 2511-2514
  • [15] Alitalo K(2003)Coadministration of angiopoietin-1 and vascular endothelial growth factor enhances collateral vascularization Hum Gene Ther 14 1451-1462
  • [16] Gamble JR(2001)Angiopoietin-1 protects the adult vasculature against plasma leakage Hum Gene Ther 12 2025-2027
  • [17] Chae JK(2002)Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1 Acta Physiol Scand 176 151-159
  • [18] Thurston G(2000)Angiogenic responses of vascular endothelial growth factors in periadventitial tissue Lancet 355 213-222
  • [19] Thurston G(2003)Clinical protocol. A phase IIb, randomized, multicenter, double-blind study of the efficacy and safety of Trinam (EG004) in stenosis prevention at the graft-vein anastomosis site in dialysis patients Cardiovasc Res 59 971-979
  • [20] Bhardwaj S(1997)Local perivascular application of low amounts of a plasmid encoding for vascular endothelial growth factor (VEGF165) is efficient for therapeutic angiogenesis in pigs Hum Gene Ther 8 1645-1650